Gastroenterology Learning Network

Dr Millie Long and her IBD Drive Time cohost, Dr Raymond Cross, talk about ways health insurers create barriers to timely treatment for inflammatory bowel disease, particularly through requirements for prior authorization.

Drs Ryan Ungaro and Priscila Santiago on Risk Factors Predicting Complicated IBD by Gastroenterology Learning Network

Dr Brian Lacy welcomes Dr Timothy Gardner to talk about acute pancreatitis.

Eric Benchimol, MD, on Pediatric IBD: The Year in Review by Gastroenterology Learning Network

The results of the ATLANTIS trial showed that patients taking amitriptyline were almost twice as likely to report an overall improvement in symptoms of irritable bowel syndrome as those taking a placebo. Co-chief investigator Alexander Ford, MD, explains the results and the implications.

In this podcast, Dr Lea Ann Chen explains how race/ ethnicity (White, Black, Hispanic, Asian) and immigration status (US-born vs foreign-born) influence IBD manifestations, disease onset, treatments, and outcomes.

Rita Knotts, MD, and Justin Henning, MD, on Diagnosing and Treating Hiatal Hernia by Gastroenterology Learning Network

In this episode of IBD Drive Time, guest Dr Adjoa Anyane-Yeboa of Massachusetts General Hospital talks with guest host Dr David Rubin of the University of Chicago about how social determinants of health can affect diagnosis and treatment of inflammatory bowel disease among marginalized communities.

Gut Check: Brian Lacy, MD, and Megan Riehl, PsyD by Gastroenterology Learning Network

Dr Cohen discusses with host Dr Raymond Cross the recent guidelines published by the American Gastroenterological Association on using biomarkers to monitor inflammatory bowel disease.